Soliris (Eculizumab) Market
Soliris (Eculizumab) Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Soliris (Eculizumab) Market Size and Growth
The Soliris (Eculizumab) market research reports indicate a robust growth trajectory for the drug, driven by increasing demand for its use in treating rare diseases such as paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome. The market size for Soliris is estimated to be around $4.3 billion globally.
Request Sample Report
Some key players in the Soliris (Eculizumab) market include Alexion Pharmaceuticals, Roche, Novartis, and Amgen. Alexion Pharmaceuticals is the main player in the market, developing and marketing Soliris. They have helped grow the market by expanding the drug's indications and conducting research to support its effectiveness. - Alexion Pharmaceuticals: Sales revenue of $4.391 billion
Roche: Sales revenue of $61.58 billion
Novartis: Sales revenue of $51.9 billion
Market Segmentation
By Application
AHUS
Request Sample Report
By Product
Plasma Exchange
Plasma Infusion
Market Growth
Request Sample Report
$ X Billion USD
